These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 23896892)

  • 1. Genotoxicity guidelines recommended by International Conference of Harmonization (ICH).
    Kamath GH; Rao KS
    Methods Mol Biol; 2013; 1044():431-58. PubMed ID: 23896892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotoxicity assessment of S-equol in bacterial mutation, chromosomal aberration, and rodent bone marrow micronucleus tests.
    Schwen R; Jackson R; Proudlock R
    Food Chem Toxicol; 2010 Dec; 48(12):3481-5. PubMed ID: 20875837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testing strategies in mutagenicity and genetic toxicology: an appraisal of the guidelines of the European Scientific Committee for Cosmetics and Non-Food Products for the evaluation of hair dyes.
    Kirkland DJ; Henderson L; Marzin D; Müller L; Parry JM; Speit G; Tweats DJ; Williams GM
    Mutat Res; 2005 Dec; 588(2):88-105. PubMed ID: 16326131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationale of genotoxicity testing of nanomaterials: regulatory requirements and appropriateness of available OECD test guidelines.
    Warheit DB; Donner EM
    Nanotoxicology; 2010 Dec; 4():409-13. PubMed ID: 20925448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. International Conference on Harmonisation; guidance on S2(R1) Genotoxicity Testing and Data Interpretation for Pharmaceuticals intended for Human Use; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2012 Jun; 77(110):33748-9. PubMed ID: 22675782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ICH-harmonised guidances on genotoxicity testing of pharmaceuticals: evolution, reasoning and impact.
    Müller L; Kikuchi Y; Probst G; Schechtman L; Shimada H; Sofuni T; Tweats D
    Mutat Res; 1999 May; 436(3):195-225. PubMed ID: 10354523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity.
    Kirkland D; Aardema M; Henderson L; Müller L
    Mutat Res; 2005 Jul; 584(1-2):1-256. PubMed ID: 15979392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategy for genotoxicity testing: hazard identification and risk assessment in relation to in vitro testing.
    Thybaud V; Aardema M; Clements J; Dearfield K; Galloway S; Hayashi M; Jacobson-Kram D; Kirkland D; MacGregor JT; Marzin D; Ohyama W; Schuler M; Suzuki H; Zeiger E;
    Mutat Res; 2007 Feb; 627(1):41-58. PubMed ID: 17126066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative overview of current international strategies and guidelines for genetic toxicology testing for regulatory purposes.
    Cimino MC
    Environ Mol Mutagen; 2006 Jun; 47(5):362-90. PubMed ID: 16649190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Considerations on photochemical genotoxicity. II: report of the 2009 International Workshop on Genotoxicity Testing Working Group.
    Lynch AM; Guzzie PJ; Bauer D; Gocke E; Itoh S; Jacobs A; Krul CA; Schepky A; Tanaka N; Kasper P
    Mutat Res; 2011 Aug; 723(2):91-100. PubMed ID: 21296679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experiences with the in vivo and in vitro comet assay in regulatory testing.
    Frötschl R
    Mutagenesis; 2015 Jan; 30(1):51-7. PubMed ID: 25527728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of genotoxicity induced by 7,12-dimethylbenz(a)anthracene or diethylnitrosamine in the Pig-a, micronucleus and Comet assays integrated into 28-day repeat dose studies.
    Shi J; Krsmanovic L; Bruce S; Kelly T; Paranjpe M; Szabo K; Arevalo M; Atta-Safoh S; Debelie F; LaForce MK; Sly J; Springer S
    Environ Mol Mutagen; 2011 Dec; 52(9):711-20. PubMed ID: 21976072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Report of the IWGT working group on strategies and interpretation of regulatory in vivo tests I. Increases in micronucleated bone marrow cells in rodents that do not indicate genotoxic hazards.
    Tweats DJ; Blakey D; Heflich RH; Jacobs A; Jacobsen SD; Morita T; Nohmi T; O'Donovan MR; Sasaki YF; Sofuni T; Tice R;
    Mutat Res; 2007 Feb; 627(1):78-91. PubMed ID: 17116417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genotoxicity risk assessment: a proposed classification strategy.
    Dearfield KL; Cimino MC; McCarroll NE; Mauer I; Valcovic LR;
    Mutat Res; 2002 Nov; 521(1-2):121-35. PubMed ID: 12438010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the genotoxic potential of single-wall carbon nanotubes by using a battery of in vitro and in vivo genotoxicity assays.
    Naya M; Kobayashi N; Mizuno K; Matsumoto K; Ema M; Nakanishi J
    Regul Toxicol Pharmacol; 2011 Nov; 61(2):192-8. PubMed ID: 21821090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotoxicity evaluation of sesamin and episesamin.
    Hori H; Takayanagi T; Kamada Y; Shimoyoshi S; Ono Y; Kitagawa Y; Shibata H; Nagao M; Fujii W; Sakakibara Y
    Mutat Res; 2011 Feb; 719(1-2):21-8. PubMed ID: 20937410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. International regulatory requirements for genotoxicity testing for pharmaceuticals used in human medicine, and their impurities and metabolites.
    Galloway SM
    Environ Mol Mutagen; 2017 Jun; 58(5):296-324. PubMed ID: 28299826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of in vivo genotoxicity assessment: combination of acute tests and integration into standard toxicity testing.
    Rothfuss A; Honma M; Czich A; Aardema MJ; Burlinson B; Galloway S; Hamada S; Kirkland D; Heflich RH; Howe J; Nakajima M; O'Donovan M; Plappert-Helbig U; Priestley C; Recio L; Schuler M; Uno Y; Martus HJ
    Mutat Res; 2011 Aug; 723(2):108-20. PubMed ID: 21182982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotoxicity testing of pidotimod in vitro and in vivo.
    Adams K; Allen JA; Brooker PC; Henderson L; Jones E; Proudlock RJ; Mailland F; Coppi G
    Arzneimittelforschung; 1994 Dec; 44(12A):1454-9. PubMed ID: 7857341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Examination of the potential genotoxicity of pure capsaicin in bacterial mutation, chromosome aberration, and rodent micronucleus tests.
    Proudlock R; Thompson C; Longstaff E
    Environ Mol Mutagen; 2004; 44(5):441-7. PubMed ID: 15517568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.